Amplification of MDM2 and Loss of p16 Expression: Do They Have a Role in Malignant Transformation of Ovarian Brenner Tumor?

Lucy Lu Wang, Douglas Allison, Pratibha S. ShuklaAmerican 2020 · DOI

Abstract

We are the first to report immunohistochemical expression of MDM2 in an MBT. Amplification of MDM2 and loss of p16 expression may have a role in malignant transformation of BT.
BibTeX
@inproceedings{wang2020amplification,
  author = {Lucy Lu Wang and Douglas Allison and Pratibha S. Shukla},
  title = {{Amplification of MDM2 and Loss of p16 Expression: Do They Have a Role in Malignant Transformation of Ovarian Brenner Tumor?}},
  booktitle = {American},
  year = {2020},
  doi = {10.1093/ajcp/aqaa033},
}

Loading related content...

Figure